Conflict of interest declaration: Paul Hilton

Updated on: 15 February 2021

Roles in: Incontinence Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the CRG?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
No

b) Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events?
No

c) Fees for organising education?
No

d) Grants and contracts?
No

e) Funds for a member of staff?
No

f) Fees for consulting?
No

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the CRG?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the CRG?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the CRG?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - NO COMPETING INTERESTS WITHIN KAST 36 MONTHS Previous commercial research funding from Gynecare (1998 to 2003) and Gynae Ideas (2001 to 2003); reimbursement of travel expenses to attend meetings in connection with these studies. Chair of the NICE guideline development group on urinary incontinence in women (2004 to 2007); received an honorarium and travel expenses in association with this role. Member of the NICE Interventional Procedures Advisory Committee, NCC-HTA Therapeutic Procedures Panel (2007 to 2008) and Clinical Evaluations and Trials Prioritisation Group (2008 to 2010), and the International Consultation on Incontinence section on surgery in women (2007 to 2009); reimbursement of, or contribution to, travel expenses was received in respect of these activities. Member of The Scottish Independent Review of the Use, Safety and Efficacy of Transvaginal Mesh Implants in the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in Women (2014-2017), and commissioned by the NHS National Services Scotland Central Legal Office, to provide expert advice in relation to legal claims relating to the use of mesh in gynaecological surgery (2014-2018); travel expenses were reimbursed in respect of both these activities, and payment was received in respect of the latter. Married to a consultant urogynaecologist, who is also a proposed Cochrane author.